Pharmacy Question for the Week of July 31, 2017

Pharmacy Compliance Question of the Week


Can you provide any information related to the CMS plan to decrease the 340B program payments in 2018?


For 2018, the Centers for Medicare & Medicaid Services (CMS) has proposed paying providers purchasing drugs under the 340B program at significantly lower rates. Specifically, for separately payable drugs and biologicals (other than drugs on pass-through and vaccines) acquired under the 340B program from the average sales price  (ASP) plus 6 percent to ASP minus 22.5 percent. In addition, CMS stated its intent to establish a modifier to identify whether a drug billed under the OPPS was purchased under the 340B Drug Discount Program.

The proposed rule (CMS-1678-P) can be downloaded from the Federal Register at

Disclaimer: Every reasonable effort was made to ensure the accuracy of this information at the time it was published. However, due to the nature of industry changes over time we cannot guarantee its validity after the year it was published.